HONG KONG, 17 July 2013 – Sihuan Pharmaceutical Holdings Group Ltd. announced that Anaprazole Sodium, a Category 1.1 new drug received the Approval for Clinical Studies from the State Food and Drug Administration (“SFDA”) of the People’s Republic...
Sihuan Pharmaceutical Announces 2014 Interim Results, Profit Attributable to Owners of the Company Up by 34.4%
The 31st National Pharmaceutical Industry Information Annual Conference 2014, which was convened in Qingdao on June 28, 2014, announced the Top 100 Chinese Pharmaceutical Companies in 2013. Beijing Sihuan Pharmaceutical Co., Ltd., was ranked the 37th among the Top 100.
In May 2014, Beijing Sihuan Pharm was honored the “Hundred Fastest Growing Enterprises within State Hi-Tech Zones” of Year 2013 in recognition of its remarkable growth rate on top of its annual business scale.
Langfang Gaobo Jingband Pharmaceutical has successfully passed the on-site inspection conducted by U.S. Food and Drug Administration (FDA)
Beijing Sihuan Pharm was honored the “Beijing Trustworthy Enterprises 2013” and received the Certificate of Honor and the Medal issued by Beijing Pharmaceutical Profession Association.